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Synthesis of Type 1 Lewis b hexasaccharide antigen structures 
featuring flexible incorporation of L-[U-13C6]-fucose for NMR 
binding studies  
Mark Longa, Aisling Ní Cheallaighb, Mark Reihillb, Stefan Oscarsonb, and Martina Lahmanna* 
While 13C-labelled proteins are common tools in NMR studies, lack of access to 13C-labelled carbohydrate structures has 
restricted their use. L-fucose is involved in a wide range of physiological and pathophysiological processes in mammalian 
organisms. Here, L-[U-13C6]-Fuc labelled type I Lewis b (Leb) structures have been synthesised for use in NMR binding studies 
with the Blood-group Antigen Binding Adhesin (BabA), a membrane-bound protein from the bacterium Helicobacter pylori. 
As part of this work, an efficient synthesis of a benzylated L-[U-13C6]-Fuc thioglycoside donor from L-[U-13C6]-Gal has been 
developed. The design and synthesis of an orthogonally protected tetrasaccharide precursor enabled controlled introduction 
of one or two 13C-labelled or non-labelled fucosyl residues prior to global deprotection. NMR analysis showed that it is 
straightforward to assign the anomeric centres as well as the H-5 positions to the individual fucosyl residues which are 
relevant for NMR binding studies.
Introduction 
 
Helicobacter pylori is a spiral-shaped Gram-negative bacterium, 
which causes gastric and duodenal ulcers and is a major cause 
of stomach cancer. The bacterium selectively colonises the 
gastric epithelium. 1-5 Unlike other pathogens, Helicobacter 
pylori has evolved to survive the highly acidic environment by 
metabolising urea to ammonia and carbon dioxide by a nickel 
depending urease.6 7, 8 The bacterium expresses at least five 
types of adhesins9 which enable adherence to the stomach 
epithelium and concomitant production of several cytotoxins 
that destroy stomach epithelial cells, creating painful ulcers. 
The resulting chronic inflammation promotes cell proliferation, 
and thus predisposes the host to stomach cancer. One of the 
five adhesins expressed by Helicobacter pylori is the membrane-
bound protein “Blood-group Antigen Binding Adhesin” (BabA). 
BabA binds to type I Lewis b (Leb) antigens expressed on the 
surface of gastric epithelial cells. Analyses of binding 
specificities of Helicobacter pylori strains from across the world 
suggest that BabA has evolved in response to host mucosal 
glycosylation patterns which permits Helicobacter pylori to 
adapt to its host and to maintain persistent colonisation.10-12 
A crystal structure of the carbohydrate-binding domain of BabA 
has been obtained while bound to a synthetic Lewis b structure. 
Analysis has revealed that the anchoring point for the binding 
of the glycan is the terminal disaccharide D-Gal(12) L-Fuc 
motif of the Leb hexasaccharide.13, 14 
Detailed knowledge of these carbohydrate-protein interactions 
of Helicobacter pylori is crucial for understanding the structural 
and molecular basis for resulting diseases. While 13C-labelled 
proteins are common tools in NMR studies, lack of access to 13C-
labelled carbohydrate structures has limited their use. Despite 
the difficulties arising from the need to synthesise the 13C-
labelled material, 13C-enriched glycans are gaining traction as 
valuable tools for structure determination15 and 
conformational analysis16. Conformational analysis of a ligand 
bound to a lectin can be carried out by Saturation Transfer 
Difference (STD) and Transfer Nuclear Overhauser Effect (NOE) 
NMR experiments and do not require isotopically enriched 
material.17 Intramolecular NOE uses a combination of 
unlabelled carbohydrates and labelled proteins to extrapolate 
ligand-protein interactions18, 19, while 13C-filtered NOESY can be 
used for identifying the conformation of bound ligands.20, 21 
More recently, a combination of 13C-labelled carbohydrates and 
15N (or 13C/15N) labelled proteins has been used to detail contact 
sites on the carbohydrate and the protein simultaneously.22 
Availability of 13C-labelled Leb structures would provide access 
to valuable tools for probing the interactions with BabA and 
other Leb binding proteins. 
Several strategies for the synthesis of type 1 Lewis structures 
have been reported. Danishefsky and co-workers have 
synthesised the Leb tetrasaccharide and hexasaccharide using a 
polymer-based oligosaccharide preparation method with 
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glycals as glycosyl donors.23, 24 Chernyak et al. have also 
reported the synthesis of the Leb hexasaccharide using a 
convergent synthesis involving a tetrasaccharide thioglycoside 
donor and a spacer-equipped 3’,4’-diol lactoside acceptor.25 
Furthermore, Lahmann et al. have reported the synthesis of the 
Leb hexasaccharide, forming a tetrasaccharide acceptor via a 
[2+2] glycosylation which was then di-fucosylated.26 Fournière 
et al. reported the synthesis of the Leb pentasaccharide by first 
preparing the trisaccharide backbone, followed by di-
fucosylation.27 The Leb tetrasaccharide was synthesised in 
addition to the Lea trisaccharides by Ryzhov et al.28 and Yan et 
al. 29 An enzymatic approach was also adopted by Chen and co-
workers towards the truncated Leb and Lea structures.30 
Herein, we report the synthesis of a uniformly 13C labelled 
fucosyl donor as a general building block and an improved 
preparation of Lewis b structures via a linear approach. The 
flexibility of this approach allows access to novel mono and di L-
[U-13C6]-fucose labelled Leb hexasaccharide structures, 
exemplified by the mono L-[U-13C6]-Fuc-labelled Leb 
hexasaccharide 1 and the di L-[U-13C6]-Fuc-labelled Leb 
hexasaccharide 2 (Scheme 1). 
 
 
Scheme 1. The target structures and the building blocks shown 
in a simplified retrosynthesis scheme: mono L-[U-13C6]-Fuc-
labelled Leb hexasaccharide 1, di L-[U-13C6]-Fuc-labelled Leb 
hexasaccharide 2 and the unlabelled Leb hexasaccharide 3 were 
prepared from the labelled and unlabelled building blocks 4 – 8. 
Results and discussion 
 
The easiest access to isotopically enriched monosaccharides is 
via biosynthesis, which provides 100% uniformly [U-13C] 
labelled material when the carbon source in the growth media 
is 13C labelled.31 
 
In previous syntheses of Leb hexasaccharide structures, a per-O-
benzylated fucosyl thioglycoside donor has been used 
successfully, and therefore the analogous L-[U-13C6]-Fuc 4 
(Scheme 1) was envisioned as a suitable labelled donor. Since L-
[U-13C6]-Fuc is prohibitively expensive, the less costly L-[U-13C6]-
Gal was selected as starting material. The synthetic route was 
elaborated using unlabelled D-Gal (S-24-S-29, supplementary 
material) and then applied to L-[U-13C6]-Gal (Scheme 2). Thus, 
after a near quantitative conversion of L-[U-13C6]-Gal into its 
pentaacetate 932, 33, a thiotolyl group was introduced at the 
anomeric position using p-thiocresol in the presence of BF3·Et2O 
(98% yield).34 Deacetylation of 10, followed by protection of the 
6-position as TBDMS silyl ether and subsequent benzylation of 
the remaining free hydroxy groups, furnished L-galactoside 11 
in a 75% yield over 3 steps. The silyl ether was removed with 
TBAF (12, 96% yield) and the 6-position was tosylated, 
producing a 94% yield of compound 13. Reduction with LiAlH4 
in THF (61% yield) gave the desired L-[U-13C6]-fucosyl donor 4 in 
an overall yield of 41% from L-[U-13C6]-Gal. 
 
Scheme 2. Reagents and conditions: a) 1. NaOAc, Ac2O, 140 oC, 
30 min, 99 % (9); 2. MePhSH, BF3·Et2O, CH2Cl2, rt, 2 h, 98% (10); 
b) 1. NaOMe, MeOH, rt, 30 min, 99%; 2. TBDMSCl, pyridine, 0 C 
to rt, 4 h, 95%; 3. BnBr, NaH, DMF, 0 C to rt, 2 h, 79% (11); c) 
Bu4NF, THF, rt, 16 h, 96%; d) TsCl, pyridine, rt, 3 h, 94%; e) LiAlH4, 
THF, reflux, 61%. 
 
As expected, complex coupling patterns due to 13C-1H and 13C-
13C couplings were observed for the labelled L-Fuc donor 4 in 
the 1H and 13C NMR spectra respectively but decoupling 
produced the matching spectra for the literature known 
unlabelled donor L-Fuc 535 (Supplementary Figure 1). 
 
The corresponding unlabelled L-Fuc 535, the D-GlcNH2 736,the D-
Gal 837 thioglycoside donors, and the D-Lac acceptor 638 
(Scheme 1) were prepared according to literature procedures. 
The assembly of the tetrasaccharide backbone 15 started with 
the NIS/AgOTf-mediated glycosylation at room temperature 
with D-Lac acceptor 6 and D-GlcNH2 donor 7 to give the 
corresponding 1,2-trans linked trisaccharide 1438 (58%) 
(Scheme 3). The phthalimido and acetyl protecting groups were 






































































Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name .,  2013, 00 , 1-3 | 3  
Please do not adjust margins 
Please do not adjust margins 
removed simultaneously with EDA in EtOH. Subsequent 
selective N-acetylation was performed with Ac2O in MeOH or 
toluene/MeOH (2:1, v/v), furnishing 3’’-OH acceptor 15 (76%).  
In previous studies, we observed orthoester formation as a 
common side product during the glycosylation of acceptor 15 
with the 2-O-acetyl analogue of donor 8. 2-Benzoate protected 
glycosyl donors are less prone to orthoester formation.39,40 The 
2-OBz thioglycoside donor 8 was successfully trialled and 
underwent glycosylation with acceptor 15 promoted by NIS and 
AgOTf (cat.) to furnish tetrasaccharide 16 in an 81% yield. 
 
Scheme 3. Reagents and conditions: a) 7, NIS, AgOTf (cat.), 4 Å 
molecular sieves, CH2Cl2, rt, 20 min, 58%; b) 1. EDA, EtOH, 
reflux, 16 h; 2. Ac2O, MeOH/toluene (2:1, v/v), rt, 30 min; 76% 
over 2 steps; c) 8, NIS, AgOTf (cat.), 4 Å molecular sieves, CH2Cl2, 
rt, 20 min – 2 h, 81%. 
 
The orthogonal protecting group pattern of tetrasaccharide 16 
permits the preparation of three different acceptors, and thus 
provides flexibility with respect to the position and number of L-[U-
13C6]-Fuc residues to be incorporated. One step deprotection 
exposes either the 4’’-OH group when using reductive ring opening 
conditions (acceptor 17) or the 2’’’-OH position under Zemplén 
conditions (acceptor 18), whilst sequential deprotection of both 
positions provides the corresponding diol acceptor 19. 
For the synthesis of the fully protected 2’’’-mono L-[U-13C6]-Fuc 
labelled Leb hexasaccharide 22 (Scheme 3), tetrasaccharide 16 
was subjected to reductive ring-opening conditions with 
NaBH3CN and HCl/Et2O in THF to reveal the 4’’-OH, giving 
acceptor 17 (85%).41,42 Acceptor 17 underwent glycosylation 
with L-Fuc donor 5 using Lemieux’s halide-assisted 
methodology to ensure α-selectivity. 43 This produced 
pentasaccharide 20 in a moderate yield of 45%. The removal of 
the 2’’’-benzoyl group under Zemplén conditions required 
extended reaction times and a slightly elevated temperature in 
order to unmasked the second fucosylation site (21, 93%). The 
L-[U-13C6]-Fuc residue was installed using donor 4 and Lemieux’s 
halide-assisted glycosylation conditions, and the 2’’’-mono L-[U-
13C6]-Fuc labelled Leb hexasaccharide 22 was obtained in a 79% 
yield. A similar reaction sequence with stepwise introduction of 
the fucosyl residues was also carried out with acceptor 18 to 
give the unlabelled 2’’’-fucosylated pentasaccharide (73%). 
Subsequent reductive ring-opening of the benzylidene acetal 
(66%) and a repeated fucosylation with unlabelled L-Fuc donor 
4 provided the fully protected, unlabelled Leb hexasaccharide 
24, demonstrating the feasibility of this approach to access also 
the 4’’- mono L-[U-13C6]-Fuc labelled Leb hexasaccharide. 
 
 
Scheme 4. Reagents and conditions: a) NaBH3CN, 2 M HCl/Et2O, 
3 Å molecular sieves, THF, rt, 40 min, 85%; b) Br2, Et4NBr, 4 Å 
molecular sieves, CH2Cl2/DMF (9:1, v/v), rt, 16 h (donor 5: 20, 
45%; donor 4: 22, 79%; 4: 23, 52%; 5: 24, 80%); c) 1 M 
NaOMe/MeOH, MeOH, rt to 40 C (21, 26 h, 93%) and 1 M 
NaOMe/MeOH, MeOH/CH2Cl2 7:1, rt to 40 C (18, 48 h, 73%) 
and (19, 64 h, 88%). 
 
The di-L-[U-13C6]-Fuc labelled hexasaccharide 23 and unlabelled 
Leb hexasaccharide 24 are also accessible from diol acceptor 19 
obtained from tetrasaccharide 17 by debenzoylation (88%, 
Scheme 4). Interestingly, this transesterification was even 
slower than the corresponding reaction on the mono 
fucosylated pentasaccharide 21. As above, the unlabelled L-Fuc 
donor 5 was converted into the corresponding bromide in the 
presence of acceptor diol 19, with the glycosylation facilitated 
by Et4NBr to give the protected unlabelled hexasaccharide 24 in 
an 80% yield (Scheme 4). The same halide-assisted glycosylation 
conditions were applied to the L-[U-13C6]-Fuc donor 4 and diol 
acceptor 19 to produce the di-L-[U-13C6]-Fuc labelled 
hexasaccharide 23 in a moderate yield (52%). 
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3, R1,R2=-L-Fuc  
Scheme 5. Reagents and conditions: a) H2, Pd/C, 0.1 M aq. HCl, 
1,4-dioxane/H2O (3:1, v/v), rt, 2 d, (1, 87%; 2, 30%; 3, 96%). 
 
The three hexasaccharides 22, 23 and 24 were globally 
deprotected by Pd-catalysed hydrogenolysis to give targets 1, 2 
and 3 respectively. A variety of hydrogenolysis conditions were 
attempted. The presence of aqueous HCl was found to be 
crucial for efficient progression of the reaction in all cases, while 
a range of solvents were tolerated. The use of a mixture of 
heterogeneous catalysts (Pd/C and Pd(OH)2/C) was found to be 
beneficial in similar unpublished work but not for the 
compounds presented here. Applying optimised conditions, the 
deprotections proceeded very well for both the 2’’’-mono L-[U-
13C6]-Fuc hexasaccharide 22 and the unlabelled hexasaccharide 
24, giving the mono-labelled (1, 87%) and unlabelled (3, 96%) 
Leb hexasaccharides in excellent yields. After deprotection of 
23, a low yield of the di-L-[U-13C6]-Fuc labelled hexasaccharide 2 
(30%) was recorded. 
 
1H NMR and 1H-13C-HSQC was used to assign most of the signals 
and a CLIP-HSQC experiment confirmed the presence of two α-
Fuc linkages and β-linkages for the remaining four glycosidic 
bonds of the known unlabelled Leb hexasaccharide 3 (Figure 1 A 
and B). 1D TOCSY spectra were generated by selective 
excitation of each of the six H-1 signals individually (Figure 1 C). 
In combination with the NMR data obtained for the mono-
labelled hexasaccharide 1 (vide infra), this enabled us, to assign 
undoubtedly the anomeric and the H-5 signals - which appeared 
in the same region occupied by the anomeric signals, to the 
individual 2’’’ and the 4’’ fucosyl residues. There was no 
substantial difference in the chemical shift between the methyl 
groups of the two fucosyl residues which are otherwise distinct 
signals. The ability to distinguish between the individual fucosyl 






Figure 1. – A: 1H NMR spectrum of the unlabelled Leb 
hexasaccharide 3; B: CLIP-HSQC of 3; C: 1D TOCSY experiments 
for 3. The anomeric signals were selectively excitated to 
generate spectra for each individual residue and then compared 
to the overall 1H NMR spectrum (bottom). 
 
The 1H NMR spectrum of di-13C-labelled hexasaccharide 2 shows 
the expected additional 13C-1H couplings corresponding to the 
labelled fucosyl residues (Figure 2A) which collapsed in the 13C-
1H decoupled experiments, reassembling the corresponding 
spectrum of the unlabelled hexasaccharide 3. A standard 13C 
NMR experiment displays only the 13C enriched fucosyl 
residues, clearly showing the 13C-13C couplings, and makes it a 
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convenient experiment to verify the incorporation of labelled 
material (Figure 2B). 
 
 
Figure 2. –  A: 1H NMR spectrum of di-α-L-[U-13C6] fucosylated 2 with 13C-1H couplings visible (bottom, red), 13C-1H decoupled 
spectrum of 2 (middle, blue), and for comparison the 1H NMR spectrum of the unlabelled hexasaccharide 3 (top, green); B: 13C 
NMR spectrum of the di-α-L-[U-13C6] fucosylated hexasaccharide 2. Only the signals from the uniformly labelled fucosyl residues 
are visible; C: Direct comparison of the 13C NMR spectrum of mono 2’’’-α-L-[U-13C6] fucosylated hexasaccharide 1 (bottom, red) 
with the 13C NMR spectrum of the di labelled hexasaccharide 2 (top, blue) allows unambiguous identification of the anomeric 
carbons of the fucosyl residues. There is no significant difference in the C-6 shifts between the fucosyl residues; D: The coupled 
(bottom, red) and 13C-1H decoupled (top, blue) 1H NMR spectra of the 2’’’-α-L-[U-13C6] fucosylated hexasaccharide 1. The stacked 
view allows unambiguous assignment of the anomeric and H-5 signals for the individual fucosyl residues. 
 
The 1H NMR spectrum of the mono-labelled hexasaccharide 1 
shows again the expected 13C-1H couplings from the 2’’’-α-L-[U-
13C6] Fuc residue, while the 13C-1H decoupled spectrum overlays 
with the unlabelled hexasaccharide 3. The presence of the 13C-
1H couplings makes the identification of the anomeric proton 
and the H-5 for the 2’’’-α-1 connected Fuc residue 
straightforward (Figure 2D). This information can also be 
obtained by comparing the 13C NMR data of di-labelled 
compound 2 to the 13C NMR data for the 2’’’ mono labelled 
compound 1, which shows the anomeric carbon of the α-L-[U-
13C6] Fuc-(1→2)-β-D-Gal linkage to appear downfield to the α-L-
[U-13C6] Fuc-(1→4)-β-D-GlcNAc bond (Figure 2C). 
 
Experimental 
All experimental data are available in the supplementary file.  
Conclusions 
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In this work, an efficient synthesis of a 13C-labelled L-fucosyl 
donor was developed from L-[U-13C6]-Gal. The synthesis of the 
L-[U-13C6]-fucose donor 4 was carried out on a 500 mg scale in a 
yield of 41% over 8 steps. This uniformly 13C labelled fucosyl 
donor is a valuable building block for the preparation of labelled 
oligosaccharides for NMR binding studies. Thus, L-[U-13C6]-Fuc 
labelled type I Lewis b (Leb) structures have been synthesised 
for use in NMR binding studies with BabA, a membrane-bound 
protein from the bacterium Helicobacter pylori. An orthogonally 
protected tetrasaccharide 16 allowed the regioselective 
introduction of one or two 13C labelled fucose residues 
producing the protected 13C labelled hexasaccharides 22 and 
23. Subsequent hydrogenolysis afforded the differently 13C 
labelled hexasaccharides 1-3. NMR analysis showed that it is 
straightforward to distinguish between the differently 
positioned fucosyl residues in the oligosaccharides. Making 
those and related structures a valuable tool for NMR protein-
carbohydrate binding studies. 
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